Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 81,426 | 75,570 | 68,534 | 58,966 | 63,627 |
| Operating Income | -81,426 | -75,570 | -68,534 | -58,966 | -63,627 |
| Other Income | 75 | 121 | 137 | 395 | 609 |
| Pre-tax Income | -81,351 | -75,449 | -68,397 | -58,571 | -63,018 |
| Net Income Continuous | -81,351 | -75,449 | -68,397 | -58,571 | -63,018 |
| Net Income | $-81,351 | $-75,449 | $-68,397 | $-58,571 | $-63,018 |
| EPS Basic Total Ops | -0.53 | -0.51 | -0.46 | -0.40 | -0.47 |
| EPS Basic Continuous Ops | -0.53 | -0.51 | -0.45 | -0.40 | -0.47 |
| EPS Diluted Total Ops | -0.53 | -0.51 | -0.46 | -0.40 | -0.47 |
| EPS Diluted Continuous Ops | -0.53 | -0.51 | -0.45 | -0.40 | -0.47 |
| EBITDA(a) | $-74,451 | $-73,132 | $-66,707 | $-58,283 | $-63,334 |